UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Twenty‐five years of biologicals in IBD: What´s all the hype about?

Journal of internal medicine, 2021-10, Vol.290 (4), p.806-825

2021

Volltextzugriff (PDF)

Tula Virus as Causative Agent of Hantavirus Disease in Immunocompetent Person, Germany

Emerging infectious diseases, 2021-04, Vol.27 (4), p.1234-1237

2021

Volltextzugriff (PDF)

To STRIDE or not to STRIDE: a critique of “treat to target” in ulcerative colitis

Expert review of gastroenterology & hepatology, 2024-08, p.1-12

2024

Volltextzugriff (PDF)

Extraintestinal manifestations and complications in inflammatory bowel diseases

World journal of gastroenterology : WJG, 2006-08, Vol.12 (30), p.4819

2006

Volltextzugriff (PDF)

Extraintestinal manifestations and complications in inflammatory bowel diseases

World journal of gastroenterology : WJG, 2006-08, Vol.12 (30), p.4819

2006

Volltextzugriff (PDF)

Prioritization in inflammatory bowel disease therapy

Expert review of gastroenterology & hepatology, 2023-08, Vol.ahead-of-print (ahead-of-print), p.1-15

2023

Volltextzugriff (PDF)

To STRIDE or not to STRIDE: a critique of "treat to target" in Crohn´s disease

Expert review of gastroenterology & hepatology, 2023-12, Vol.17 (12), p.1205-1219

2023

Volltextzugriff (PDF)

Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease

PloS one, 2009-02, Vol.4 (2), p.e4496-e4496

2009

Volltextzugriff (PDF)

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations

Journal of Crohn's & colitis, 2013-02, Vol.7 (1), p.1-33

2013

Volltextzugriff (PDF)

Clinical outcome, risk assessment, and seasonal variation in hospitalized COVID-19 patients—Results from the CORONA Germany study

PloS one, 2021-06, Vol.16 (6), p.e0252867-e0252867

2021

Volltextzugriff (PDF)

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

Gut, 2010-06, Vol.59 (6), p.752-759

2010

Volltextzugriff (PDF)

Thiopurine treatment in inflammatory bowel disease : Clinical pharmacology and implication of pharmacogenetically guided dosing

Clinical pharmacokinetics, 2007-01, Vol.46 (3), p.187-208

2007

Volltextzugriff (PDF)

Mechanisms of Disease: defensins in gastrointestinal diseases

Nature clinical practice. Gastroenterology & hepatology, 2005-09, Vol.2 (9), p.406-415

2005

Volltextzugriff (PDF)

Comparison of machine learning methods with logistic regression analysis in creating predictive models for risk of critical in-hospital events in COVID-19 patients on hospital admission

BMC medical informatics and decision making, 2022-11, Vol.22 (1), p.309-309, Article 309

2022

Volltextzugriff (PDF)

High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study

Oncology research and treatment, 2023-05, Vol.46 (5), p.201-210

2023

Volltextzugriff (PDF)

Prognostic Impact of Acute Cardiovascular Events in COVID-19 Hospitalized Patients—Results from the CORONA Germany Study

Journal of clinical medicine, 2021-09, Vol.10 (17), p.3982

2021

Volltextzugriff (PDF)

Inducible and constitutive β‐defensins are differentially expressed in Crohn's disease and ulcerative colitis

Inflammatory bowel diseases, 2003-07, Vol.9 (4), p.215-223

2003

Volltextzugriff (PDF)

JAK-Inhibitoren: eine neue Therapieoption

Gastro-News, 2022-04, Vol.9 (2), p.38-40

2022

Volltextzugriff (PDF)

Response of refractory colitis to intravenous or oral tacrolimus (FK506)

Inflammatory bowel diseases, 2002-09, Vol.8 (5), p.317-324

2002

Volltextzugriff (PDF)

Therapie-Update Morbus Crohn 2021

Gastro-News, 2021-10, Vol.8 (5), p.26-33

2021

Volltextzugriff (PDF)

Crohn's disease: a defensin deficiency syndrome?

European journal of gastroenterology & hepatology, 2003-06, Vol.15 (6), p.627-634

2003

Volltextzugriff (PDF)

Volume and Quality in Visceral Medicine

Visceral medicine, 2017-05, Vol.33 (2), p.104-105

2017

Volltextzugriff (PDF)

Differences between Treatment Guidelines - Germany

Digestive diseases (Basel), 2013-01, Vol.31 (3-4), p.357-359

Herrlinger, Klaus R.

2013

Volltextzugriff (PDF)

Arguments for and against Centralization in Oncologic Visceral Medicine

Visceral medicine, 2017-05, Vol.33 (2), p.148-152

2017

Volltextzugriff (PDF)

1 – 25 von 128

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(80)

Publikationsform

Sprache

Englisch
(82)
Deutsch
(49)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Twenty‐five years of biologicals in IBD: What´s all the hype about?

Tula Virus as Causative Agent of Hantavirus Disease in Immunocompetent Person, Germany

To STRIDE or not to STRIDE: a critique of “treat to target” in ulcerative colitis

Extraintestinal manifestations and complications in inflammatory bowel diseases

Extraintestinal manifestations and complications in inflammatory bowel diseases

Prioritization in inflammatory bowel disease therapy

To STRIDE or not to STRIDE: a critique of "treat to target" in Crohn´s disease

Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations

Clinical outcome, risk assessment, and seasonal variation in hospitalized COVID-19 patients—Results from the CORONA Germany study

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

Thiopurine treatment in inflammatory bowel disease : Clinical pharmacology and implication of pharmacogenetically guided dosing

Mechanisms of Disease: defensins in gastrointestinal diseases

Comparison of machine learning methods with logistic regression analysis in creating predictive models for risk of critical in-hospital events in COVID-19 patients on hospital admission

High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study

Prognostic Impact of Acute Cardiovascular Events in COVID-19 Hospitalized Patients—Results from the CORONA Germany Study

Inducible and constitutive β‐defensins are differentially expressed in Crohn's disease and ulcerative colitis

JAK-Inhibitoren: eine neue Therapieoption

Response of refractory colitis to intravenous or oral tacrolimus (FK506)

Therapie-Update Morbus Crohn 2021

Crohn's disease: a defensin deficiency syndrome?

Volume and Quality in Visceral Medicine

Differences between Treatment Guidelines - Germany

Arguments for and against Centralization in Oncologic Visceral Medicine

Suchergebnisse filtern